Wells Fargo Lowers Price Target for Colgate-Palmolive Despite Maintaining "Underweight" Rating

Wells Fargo maintains "Underweight" rating for Colgate-Palmolive and lowers price target to $80.00 from $83.00. The adjustment reflects ongoing evaluations by analysts regarding Colgate-Palmolive's market positioning and financial outlook. Investors are advised to consider these ratings when making investment decisions.

Wells Fargo has maintained its "Underweight" rating for Colgate-Palmolive (NYSE: CL) but has lowered the price target from $83.00 to $80.00, reflecting ongoing evaluations of the company's market positioning and financial outlook. The adjustment was made by Wells Fargo analyst Chris Carey on September 25, 2025 Wells Fargo Maintains Colgate-Palmolive (CL) Underweight Recommendation^[1].

This latest move follows a series of price target reductions by various analysts in recent months. On August 4, 2025, Wells Fargo had already lowered the price target from $88.00 to $83.00, and other major analysts like Morgan Stanley, JP Morgan, and Citigroup have also adjusted their price targets, indicating a cautious approach to the company's stock CL: Wells Fargo Lowers Price Target for Colgate-Palmolive | CL Stock News^[2].

Colgate-Palmolive, founded in 1806, is a leading player in the household and personal care industry. It manufactures a wide range of products, including oral care, shampoos, shower gels, deodorants, and home care products, sold in over 200 countries. International sales account for approximately 70% of its total business, with a significant portion coming from emerging regions. The company also owns Hill's, a specialty pet food maker, which generates around one-fifth of its sales CL: Wells Fargo Lowers Price Target for Colgate-Palmolive | CL Stock News^[2].

Analysts' forecasts indicate a mixed sentiment. Based on one-year price targets from 19 analysts, the average target price is $94.75, with a high estimate of $106.00 and a low estimate of $79.00. This average target implies an upside of 16.47% from the current price of $81.35 CL: Wells Fargo Lowers Price Target for Colgate-Palmolive | CL Stock News^[2]. The consensus recommendation from 21 brokerage firms is "Outperform," indicating a positive outlook despite the recent price target reductions CL: Wells Fargo Lowers Price Target for Colgate-Palmolive | CL Stock News^[2].

Investors are advised to consider these ratings and forecasts when making investment decisions. The ongoing evaluations by analysts suggest a cautious approach to Colgate-Palmolive's stock, reflecting a potential shift in market sentiment.